Inventor · disambiguated record
R. Kent Hermsmeyer
Also filed as: HERMSMEYER R KENT
7 granted patents·5 pending applications·326 citations·filing 1998–2012
89Inventor score
Top patents by PatentIndex Score
12 records- 0194US8420111B2Method and kit for reducing the symptoms of peripheral vascular diseaseHERMSMEYER R KENT·Filed 2012·Granted Apr 16, 2013·50 cites·14 claims
- 0294US8182833B2Method and kit for reducing the symptoms of peripheral vascular disease with topical progesteroneHERMSMEYER R KENT·Filed 2009·Granted May 22, 2012·50 cites·7 claims
- 0393US6511969B1Method for reducing coronary artery reactivityDIMERA LLC·Filed 2000·Granted Jan 28, 2003·58 cites·6 claims
- 0491US7674783B2Estrogen beta receptor agonists to prevent or reduce the severity of cardiovascular diseaseDIMERA INC·Filed 2003·Granted Mar 9, 2010·51 cites·16 claims
- 0591US7572780B2Method and kit for reducing the symptoms of peripheral vascular diseaseDIMERA INC·Filed 2003·Granted Aug 11, 2009·51 cites·21 claims
- 0683US6056972AMethod for reducing coronary artery reactivityDIMERA LLC·Filed 1998·Granted May 2, 2000·64 cites·22 claims
- 0768US6602487B1Methods and tests for producing and for inhibiting coronary artery vasospasmsDIMERA INC·Filed 2000·Granted Aug 5, 2003·2 cites·5 claims
- 0864US2008071247A1Topical administration of a salt compound to facilitate venipunctureDIMERA INC·Filed 2007·Application pending·0 cites
- 0950US2010152144A1Estrogen beta receptor agonists to prevent or reduce the severity of cardiovascular diseaseHERMSMEYER R KENT·Filed 2010·Application pending·0 cites
- 1050US2010234766A1Topical administration of a salt compound to facilitate venipunctureHERMSMEYER R KENT·Filed 2010·Application pending·0 cites
- 1148US2003119799A1Method for reducing coronary artery reactivityFiled 2002·Application pending·0 cites
- 1247US2003186954A1Estriol to treat and prevent cardiovascular diseaseFiled 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when R. Kent Hermsmeyer files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →